global view constructed of white lines

Blog

November Clinical Trials at PNI
December 2, 2020

Clinical Trials Round-Up: December 2020

by Mini Gill

New Studies Blue Earth Diagnostics FLC-219: (PDF): An Open-label, Single-arm, Single-dose, Prospective, Multicenter Phase 2b Study to Establish Image Interpretation Criteria for 18F-Fluciclovine Positron Emission Tomography (PET) in Detecting Recurrent Brain Metastases After Radiation Therapy (PURSUE) (NCT04410367) Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A...

November Clinical Trials at PNI
November 2, 2020

Clinical Trials Round-Up: November 2020

by Mini Gill

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma (NCT03463265) Orbus Therapeutics (PDF): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...

Dementia with Lewy Bodies Phase 2 Clinical Trial
October 30, 2020

New Drug for Lewy Body Dementia Shows Promise

by Guest Author

Drug shows encouraging signs for patients of less common type of dementia. Pacific Neuroscience Institute located at Providence Saint John’s Health Center among sites for clinical trial.

Clinical Trials Round Up October 2020 Cover
October 2, 2020

Clinical Trials Round-Up: October 2020

by Mini Gill

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma (NCT03463265) Orbus Therapeutics (PDF): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...

Clinical Trials August 2020 Cover
September 1, 2020

Clinical Trials Round-Up: September 2020

by Mini Gill

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience ( PDF ): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma ( NCT03463265 ) Orbus Therapeutics ( PDF ): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...

Clinical Trials Round Up July 2020
August 4, 2020

Neuroscience Clinical Trials Round-Up: July 2020

by Mini Gill

Find out about the new and ongoing neuroscience clinical trials at Pacific Neuroscience Institute, addressing difficult diseases such as brain tumors.

July 22, 2020

Glioblastoma (GBM) Awareness Day – A Difficult Brain Tumor

by Mini Gill

July 22, 2020 is Glioblastoma Awareness Day. Glioblastoma (GBM) is one of the most notorious forms of brain cancer and one of the most challenging malignancies to treat in all of oncology.

AI images over a woman's face
May 18, 2020

Using AI as an Early Detector of Cognitive Decline

by Zara Jethani

Pacific Neuroscience Institute’s Pacific Brain Health Center, an outpatient clinic of the Providence Saint John’s Health Center in Santa Monica, CA, is the site for an IRB approved study from Evoke Neuroscience.

COVID-19 Image
April 22, 2020

Lightning Fast COVID-19 Response at Providence Saint John’s Health Center

by Zara Jethani

An antiviral and an anti-inflammatory therapy against COVID-19, and convalescent plasma are currently in clinical trials at Providence Saint John’s Health Center in Santa Monica, CA.

Nurse holding a bag of plasma
April 21, 2020

COVID-19 Convalescent Plasma Trial: Urgent Call For Blood Plasma Donations

by Zara Jethani

A new trial treatment using blood plasma donations from people who have fully recovered from COVID-19 infection may be helpful in treating other patients with COVID-19.

Last updated: May 5th, 2020